Fangzhou (SEHK:6086) Stock Faces 99x P E As Profit Thins

The market has treated Fangzhou like a high‑multiple growth story, yet the stock closed at just HK$0.69 after these H1 numbers, with only a modest move over the past week. The headline this time is simple: Revenue reached ¥1,824.5m for the half and the company stayed in the black, with basic earnings per share of ¥0.01.

That keeps Fangzhou technically profitable over the last twelve months, but with TTM earnings of only ¥8.3m against a P/E near 99x, the valuation strain remains the key lens for this quarter’s print.

Is Fangzhou trading like a bubble stock on a 99x P/E, or does the DCF estimate hint at a mispriced opportunity? Compare that gap directly in the full valuation analysis for Fangzhou

H1 2026 Earnings Summary

• Revenue, H1 2026 vs H1 2025: ¥1,824.5m vs. ¥1,493.6m (change of about 22%)
• Net Income, H1 2026 vs H1 2025: ¥8.9m vs. ¥12.5m (decline of about 29%)
• Basic EPS, H1 2026 vs H1 2025: ¥0.01 vs. ¥0.0094 (change of about 7%)
• Trailing Twelve Month Revenue, H1 2026 vs H1 2025: ¥3,857.1m vs. ¥2,878.1m (change of about 34%)

If you prefer clean, visual charts instead of another wall of earnings tables and ratios, explore Fangzhou’s full financial picture, including how its valuation compares with recent results, in the interactive company report for Fangzhou.

Fangzhou revenue momentum versus thin profitability

For bullish investors, Fangzhou offers a mixed picture. Revenue of ¥1,824.5m in H1 2026 compared with ¥1,493.6m in H1 2025 and trailing twelve month revenue of ¥3,857.1m compared with ¥2,878.1m point to a business that is still gathering top line scale across its chronic disease and online pharmacy platform. At the same time, the company only delivered H1 net income of ¥8.9m and basic EPS of ¥0.01, which keeps the growth story alive but shows limited profit capture from that broader revenue base.

Fangzhou earnings quality and sentiment risk checks

The bearish narrative around Fangzhou focuses on margin pressure, competition and sentiment swings in Chinese digital health. H1 2026 net income declined from ¥12.5m to ¥8.9m even as revenue moved higher, which points to pressure on profitability that fits those concerns. Trailing twelve month earnings of ¥8.3m on a much larger revenue base also underline how thin current margins are. The share price is roughly flat over 7 days but down about 24% over 90 days, which suggests the market is already wary about how durable this earnings profile is.

With Fangzhou running thin margins while the share price has already reacted after these results, investors may want to stress test whether this is just normal earnings noise or an early sign of deeper issues. Review our independent risk analysis for Fangzhou which shows 2 important warning signs

Stay Ahead Of Your Next Move

If Fangzhou’s thin margins and high P/E have your attention, register for free with Simply Wall St and add it to a Watchlist so you can track the share price against fair value and watch for an entry point that suits your plan. Once you own Fangzhou or any other stock, use the Portfolio Command Center to cut through the noise and get focused alerts on the updates that matter most. For a broader view, tap into the collective insight of other investors through the Community and see how different perspectives line up against your own. This way you are set up to spot potential catalysts or risks early and keep a step ahead of the market.

Seeking Alternatives Beyond Fangzhou?

Fresh ideas move fast. Some stocks are building quiet breakout momentum while others are still under the radar for now. Before the crowd catches up, consider making your move sooner rather than later.

• Spot resilient potential compounders by scanning the curated 305 resilient stocks with low risk scores that aim to keep downside in check while you focus on long term compounding opportunities.
• Hunt for income workhorses by reviewing the hand picked 417 dividend fortresses that may help you target steadier cash flows while prices still look reasonable.
• Go where demand for critical materials could stay intense by checking the focused 9 top copper producer stocks and locate miners that might be gearing up for the next supply squeeze.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com